Tag Archives: goal

Sports

Jeopardy contestant takes shot at Packers’ field goal on Aaron Rodgers’ first show

Leave a comment

Getty Images

Packers quarterback Aaron Rodgers made his debut as guest host on Jeopardy today, and one contestant took the opportunity to address the way the Packers’ season came to an end.

On Final Jeopardy, when the contestants write down their answers to the last clue, one contestant didn’t try to answer and instead referenced the ending of the Packers’ NFC Championship Game loss to the Buccaneers, when Packers coach Matt LaFleur chose to kick a field goal on fourth-and-goal instead of keeping Rodgers on the field to try to score a touchdown and tie the game with a two-point conversion.

“Who wanted to kick that field goal?” the contestant wrote.

Rodgers responded, “That is a great question. Should be correct, but unfortunately for this game today it’s incorrect.”

After the Packers’ loss, Rodgers made clear that the field goal was not his decision, although he also said he understood LeFleur’s thinking.

Read original article here

Health

Biden will announce new vaccine goal of 200 million shots by first 100 days in office

Leave a comment

The Biden administration on Thursday announced new plans to allocate Covid-19 vaccines to dialysis centers nationwide. This new partnership with dialysis clinics is an effort to vaccinate people receiving dialysis, as well as health care personnel in outpatient dialysis clinics. 

Dr. Rochelle Walensky, director of the US Centers for Disease Control and Prevention, applauded the partnership in a written statement released on Thursday, saying that she is “proud” the CDC has partnered with dialysis provider organizations to support the vaccination of most dialysis patients and health care personnel.

“This effort is another important step in making sure that vaccines reach the most medically vulnerable communities and that equity continues to anchor our efforts to end the COVID-19 pandemic,” Walensky said in the statement. 

Dialysis is used to treat people with kidney failure, which affects more than half a million people in the United States, and most people go to a dialysis center for treatment.

“Each year, more than 550,000 people receive regular dialysis treatments through the Medicare End-Stage Renal Disease Program. The dialysis partners effort will onboard clinics that participate in the Medicare program to administer COVID-19 vaccines to their patients and workers,” Walensky said, adding that dialysis facilities already have “longstanding” experience administering vaccinations, such as flu and hepatitis B shots.

Walensky added that people on dialysis often have more severe outcomes when they contract Covid-19, half require hospitalization and 20% to 30% die, she said.

“Furthermore, advanced stage chronic kidney disease disproportionately affects racial and ethnic minorities, including African Americans, Hispanics, and American Indians/Alaska Natives,” Walensky said. “Dialysis clinics provide a trusted innovative pathway to help COVID-19 vaccines reach populations that have been disproportionately affected by the COVID-19 pandemic.” 

In response, the nonprofit American Kidney Fund issued a statement on Thursday applauding the White House’s decision to distribute Covid-19 vaccines to dialysis centers. The American Society of Nephrology tweeted a link to the White House’s announcement about the dialysis program, calling it “big news.”

Read original article here

Business

Biden administration not confident Johnson & Johnson will meet 20 million goal by end of month

Leave a comment

The US Food and Drug Administration granted Johnson & Johnson’s coronavirus vaccine emergency use authorization nearly a month ago, but the company has struggled to ramp up production, been slow to submit paperwork and failed to meet production timelines laid out in the company’s contract with the federal government. With only days left to deliver nearly 14.8 million vaccines, administration officials are hedging their bets on whether Johnson & Johnson will deliver based on past behavior.

While the Biden administration has worked to ramp up supply of all three authorized vaccines, the Johnson & Johnson product has multiple advantages over the other two because it’s one dose instead of two and lasts in a refrigerator for three months as opposed to being frozen.

“At this point in time, I don’t want to commit to what’s going to happen over the course of the coming week. We’ll leave that to the company,” Andy Slavitt, the White House’s Covid-19 senior adviser, told reporters Monday.

As the Covid-19 pandemic swept the nation last spring, the US government signed a $450 million contract with Johnson & Johnson for vaccine research and development. In August, the federal government announced it would pay the company another $1 billion for 100 million doses of its potential coronavirus vaccine, months before the company would win authorization from the FDA. Under that contract, Johnson & Johnson was scheduled to have 37 million doses ready by the end of March and 100 million by the end of June. But now the company is at risk of not meeting the 20 million mark by the end of this month.

Despite efforts by the federal government to compress production timelines, Johnson & Johnson only had four million doses ready to ship when it was authorized by the FDA at the end of February. An additional 1.2 million doses have gone out since, meaning the company must have another 14.8 million ready in the next week to meet its goal.

Johnson & Johnson told CNN Monday that it is still on track to meet its March deadline. In February, the company promised to “deliver enough single-doses by the end of March to vaccinate more than 20 million Americans,” at a congressional oversight subcommittee in February.

Administration officials, who spoke on the condition of anonymity in order to comment on internal discussions, said they aren’t willing to guarantee those millions will be ready within the next week. They’re hopeful, but not positive, because the delivery schedule has not accelerated in the way officials had hoped, one told CNN.

Though they have been frustrated privately, the Biden administration has been hesitant to publicly criticize Johnson & Johnson over delays. The government has worked closely with the company to speed up the process, including using the Defense Production Act to obtain materials and equipment and the President recently announced they had brokered a rare partnership between Johnson & Johnson and the pharmaceutical giant Merck & Co. to make more vaccines, though the results of that joint venture won’t be felt until later this year.

In February, Johnson & Johnson said it had been working to expand its own manufacturing capacity with third-party vaccine manufacturers.

One part of the manufacturing chain, Catalent in Bloomington, Indiana, that does what’s known as the fill/finish part of the manufacturing process is still waiting on the sign-off from the US Food and Drug Administration to ship its doses. That plant has had teams working around the clock to fill vials with the Johnson & Johnson vaccine, so when it does get the green light, that should boost the number of available Johnson & Johnson vaccines immediately.

Catalent told CNN on Monday that it hopes to get the FDA sign-off sometime this week, and an administration official echoed that.

The official told CNN the reason Catalent has not received FDA authorization to release the doses for shipment is because Johnson & Johnson has often been slow to submit the appropriate paperwork and data, delaying the entire release process, which must follow strict protocol to obtain final clearance.

An administration official raised the possibility that Johnson & Johnson could miss its March deadline to reach 20 million coronavirus vaccines, only to reach it days later.

But, as officials and public health experts have noted, with the pandemic killing Americans daily, every day — and dose — counts.

Read original article here

Health

Biden administration frets J&J may miss vaccine goal

Leave a comment

Notably, J&J is shipping components from Europe to a U.S. “fill and finish” facility before sending the doses to the federal government, officials said. The company is also waiting for the Food and Drug Administration to authorize two key American partners, Emergent BioSolutions and Catalent, who’d send out “tens of millions” of usable shots, according to a person familiar with the process. That authorization is expected to materialize in the coming days, one individual with knowledge of the matter said, adding that it’s believed the number of doses released would be in the “millions.”

One senior Biden official said the administration does not expect the full 20 million dose shipment to be significantly postponed. But any delay would likely inflame tensions between the administration and J&J who have for weeks accused each other of creating unnecessary logjams in the rollout.

Emergent has been working on J&J’s vaccine production since early last year, and said in a statement that it plans to produce 1 billion vaccines this year for J&J and AstraZeneca, another partner in the vaccine race. But Emergent was not included in J&J’s original emergency use application, and their doses have sat unused.

The situation has frustrated administration officials as they look to deliver on President Joe Biden’s directive to offer vaccines to all U.S. adults by May.

“There is a slowness to J&J getting stuff done,” said a person familiar with the process. “They are slow to address some of this stuff. No one thinks they move fast.”

Roughly 4 million doses of J&J’s single-shot vaccine were available when the FDA authorized use of the vaccine at the end of February, after the company fell behind on its production schedule. But last month, the company told Congress that it could deliver 20 million doses to the U.S. government by the end of March.

Biden administration officials had originally banked on the single-dose J&J shot to accelerate the country’s return to normalcy, hoping it would dramatically accelerate efforts to vaccinate over 300 million Americans. As of Monday, 4.3 million of the company’s vaccines have been delivered to states, retail pharmacies, community health centers and federal vaccine sites, according to the CDC.

The White House has tiptoed around whether J&J will meet its 20 million shot commitment. Andy Slavitt, a senior adviser to the White House’s Covid team, said on Monday there will be “a nice increase” in the single-shot vaccine this week.

“We’re working with them very closely,” Slavitt said. “I wouldn’t signal to you they’re going to be far away from the numbers that they have projected at all — give or take a little bit — and obviously we’re holding them accountable and working closely with them.”

Earlier this month, the White House directed states to broadly open up eligibility for vaccinations to all adults by May 1 and laid out how the country could return to some normal activities by July 4. But those goals can only be reached through a dramatic increase in shots.

White House officials have told governors to expect roughly 4 to 6 million J&J shots next week, according to one source and notes of a call last week between administration officials and governors. Multiple states told POLITICO they are receiving some J&J vaccine this week, but there are no forecasts yet for individual allotments next week. The Biden administration has sought to give states a three-week window into the number of doses they’ll receive.

In an attempt to boost the J&J supply, pharmaceutical giant Merck will help manufacture J&J’s coronavirus vaccine. The Biden administration announced it brokered the deal earlier this month, after J&J was unable to meet its original pledge to provide 12 million doses of its vaccines by the end of February.

Read original article here

Sports

Kepa Arrizabalaga & Thomas Tuchel React to Making Semi-Finals | Chelsea 2-0 Sheffield United – Chelsea Football Club

Leave a comment

  1. Kepa Arrizabalaga & Thomas Tuchel React to Making Semi-Finals | Chelsea 2-0 Sheffield United Chelsea Football Club
  2. ‘He needs to see the dentist!’ – Tuchel confirms tooth problem will keep Mendy out of Senegal’s internation… Goal.com
  3. Chelsea vs. Sheffield United reaction: Did Christian Pulisic do enough to impress Tuchel? | ESPN FC ESPN UK
  4. Chelsea vs. Sheffield United – Football Match Report – March 21, 2021 ESPN
  5. Thomas Tuchel updates on Tammy Abraham and Edouard Mendy’s absence following Chelsea victory against Sheffiel… We Ain’t Got No History
  6. View Full Coverage on Google News

Read original article here

US

Biden to hit goal of 100 million vaccinations, as US prepares to send shots to Canada and Mexico

Leave a comment

Jen Psaki, the White House press secretary, said the US was planning to share 2.5 million doses of the vaccines with Mexico and 1.5 million with Canada.

Tens of millions of doses of the vaccine have been stockpiled at US manufacturing sites. The Oxford-AstraZeneca vaccine has been approved for use in dozens of countries, including Mexico and Canada, but the shot has not yet been authorized by American drug regulators. Psaki said the doses to be sent to the two countries would be a loan, with the US receiving vaccines in return in future.

The agreement could be finalized as soon as Friday, CNN has learned. On Tuesday, Mexico’s foreign minister said an announcement could come by the end of the week.

The Biden administration has committed to having enough vaccines for all Americans before sharing doses, and if this agreement comes together it would be the first time the US has shared vaccines directly with another country. It would also likely give a major boost to vaccination efforts in Canada and Mexico, which are struggling with their vaccine roll-outs in comparison to the US.

Friday could mark another big milestone for President Joe Biden: 100 million shots since he took office. Biden had promised to hit that number within his first 100 days in office, but he has met the goal with weeks to spare.

Commenting on the pace of the rollout on Thursday, Biden said Americans still needed to be vigilant to prevent the spread of the virus — cases are still on the rise in several states.

“This is a time for optimism but it’s not a time for relaxation,” Biden cautioned. “I need all of you to do your part. Wash your hands, stay socially distanced, keep masking up as recommended by the CDC and get vaccinated when it’s your turn.”

More than 115 million Americans have been vaccinated since the first Covid-19 shot was authorized in December, according to the latest data from the US Centers for Disease Control and Prevention.

CNN SPECIAL REPORT

The Human Cost of Covid premieres on Saturday from 9 p.m.-10 p.m. ET. The documentary will be available Sunday on demand via cable/satellite systems for CNN. It will also be available on CNNgo platforms and CNN mobile apps.

YOU ASKED. WE ANSWERED.

Q: When can Americans return to normal life?

A: States are pushing ahead with expanding Covid-19 vaccine access and rolling back restrictions on businesses and large gatherings as America seeks a return to normality.

But experts say two barriers stand in the way of reaching herd immunity and getting back to life as we knew it: Covid-19 variants and vaccine hesitancy.

“We’re neglecting the huge number of people in the middle who need, who want to get the vaccine but may have some concerns or just don’t have time to take time off of work or find child care,” emergency physician Dr. Leana Wen told CNN’s Anderson Cooper on Thursday. “We need to make vaccination easy for those individuals and also really clearly demonstrate what is the benefit of vaccination, make clear the messaging that vaccines are the pathway back to pre-pandemic life.”

Send your questions here. Are you a health care worker fighting Covid-19? Message us on WhatsApp about the challenges you’re facing: +1 347-322-0415.

WHAT’S IMPORTANT TODAY

AstraZeneca vaccine is ‘safe and effective’

The European Union’s medicines regulator said on Thursday that the Oxford-AstraZeneca Covid-19 vaccine was “safe and effective” to use after more than a dozen EU countries, including France, Germany and Italy, suspended shots following reports that they could be linked to blood clots. Denmark and Sweden said they will not restart their rollouts, despite the European Medicines Agency’s guidance.
But even when other countries resume rollouts, the World Health Organization (WHO) has warned that at their current pace, Europe’s vaccination campaigns aren’t yet slowing transmission of the coronavirus. The continent recorded more than 1.2 million new infections last week, and more than 20,000 people a week are dying of Covid-19. “The number of people dying from COVID-19 in Europe is higher now than it was this time last year, reflecting the widespread hold this virus has,” Dr. Hans Kluge, WHO’s regional director for Europe, said on Thursday.

Much of Western Europe is now in the throes of a third wave of the virus. France on Thursday announced a limited Covid-19 lockdown for Paris and several other regions to combat surging cases. And the pandemic is “moving eastwards,” Dr. Kluge said, with infection rates and deaths in Central Europe, the Balkans and Baltic states among the highest in the world.

As Covid-19 deaths soar in Brazil, Bolsonaro says there’s a ‘war’ against him

Brazil this week reported its highest daily death toll since the pandemic began, as the government appointed its fourth health minister in a year to deal with one of the world’s worst outbreaks of the virus. But Brazilian President Jair Bolsonaro continues to dispute the gravity of the crisis, suggesting that his detractors are blowing the scale of the pandemic out of proportion to wage a “war” against him politically.

“Here it became a war against the President. It seems that people only die of Covid,” Bolsonaro, who wasn’t wearing a mask, told supporters outside the presidential palace on Thursday. “The hospitals are 90% occupied. But we need to find out how many are from Covid and how many are from other illnesses,” he said.

In the coastal city of Rio de Janeiro, intensive care units are 95% full. Fifteen other state capitals are similarly verging on collapse, with ICU occupancy over 90% — a deluge of hospitalizations that has accompanied a sharp rise in Covid-19 cases in the country. While Covid-19 cases are beginning to plateau or decline in many nations, Brazil is reporting record daily numbers. More than 45,000 people have been killed in Brazil in the last month alone, and the country recorded 90,303 new cases in a single day on Wednesday.

Cubans embark on treacherous sea journeys as economic crisis worsens

When Beatriz Jimenez closes her eyes, she sees her daughter Lisbethy and two young grandchildren — and they are alive. Jimenez’s family left the small seaside town of Cabarién, on Cuba’s north coast, on March 4, aboard a packed smuggler’s boat.

Jimenez said her daughter Lisbethy took the trip because she had been apart from her husband in Florida for more than a year, after the pandemic forced Cuba to cut most international flights. Lisbethy had been afraid to leave her daughter Kenna Mariana, 6 years old, and Luis Nesto, 4, behind in Cuba and risk a lengthy separation. Their boat capsized in Bahamian waters, according to the Cuban foreign ministry. Some 12 survivors and one dead body were found by a Royal Bahamian Defence ship, but Lisbethy and her children were not among them.

A worsening economic climate could push more Cubans like Lisbethy to make the desperate voyage, despite having lost their preferential status, Patrick Oppmann reports. In 2020, the economy shrank by 11%, according to Cuban government figures, as the island’s tourism industry was almost entirely shut down by the pandemic.

ON OUR RADAR

  • Transplant surgeons at Northwestern Medicine in Illinois say they have successfully performed one of the first known double lung transplants on a Covid-19 patient using organs from a donor who had previously tested positive for the virus.
  • Researchers working to show when and how the virus first emerged in China calculate that it probably did not infect the first human being until October 2019 at the earliest. And their models showed something else: It almost didn’t make it as a pandemic virus.
  • The coronavirus spread on an international flight, in a hotel corridor and then to household contacts despite efforts to isolate and quarantine patients, New Zealand researchers reported Thursday.
  • Covid-19 restrictions at the first Super Nintendo World in Japan include temperature checks, mandatory mask-wearing, hand sanitizer everywhere, social distancing in line, and signs in front of roller coasters asking riders to refrain from screaming.
  • Officials in the South Korean capital Seoul have reversed course on controversial plans to require all foreign workers to undergo Covid-19 testing after facing a torrent of criticism from diplomatic missions and international businesses.

TOP TIPS

Are you having more nightmares? You might be ‘quaradreaming’

The phenomenon started to be noted by physicians about a year ago, not long after lockdowns began around the world. Frontline workers were hard hit — a June 2020 study of 100 Chinese nurses found 45% experienced nightmares, along with varying degrees of anxiety and depression. But nightmares have continued as quarantines and lockdowns stretched on, experts say. One reason: an increase in “night owls.”

If you are having frightening nightmares that haunt you or lead to feelings of hopelessness and depression, reach out to a mental health professional. For those experiencing less stressful “quaradreams,” Sandee LaMotte has these tips.

TODAY’S PODCAST

“There is even evidence that social isolation and loneliness influences your susceptibility to viruses and the ability to respond to a vaccine.” — Julianne Holt-Lunstad, professor of psychology and neuroscience at Brigham Young University in Provo, Utah

Today on the podcast, we check out what one neighborhood in Brooklyn is doing to bring people safely together during the pandemic, and we check in with an expert on loneliness, Dr. Holt-Lunstad, about promising new research that shows the power of small acts of kindness. Listen now.

Read original article here

US

Fact-check: Biden’s May 1 goal of getting Covid-19 vaccines to all adults is really possible

Leave a comment

President Joe Biden on Thursday announced that all adults in the US will be eligible for a Covid-19 vaccine by May 1. “All adult Americans will be eligible to get a vaccine no later than May 1,” Biden said. “That’s much earlier than expected.”

Biden clarified that adults won’t all be able to get a vaccine right away, but they will at least be able to get in line. Even then, he said the country will have enough vaccine supply for all adults by the end of May — a claim he’s made before.

It’s a goal that, as Biden said, would have seemed unfeasible just a couple of months ago. But there’s good reason to believe it’s absolutely possible now.

As of Thursday, the US has given at least one dose of the vaccine to 64 million people, with 33 million people fully vaccinated, according to the Centers for Disease Control and Prevention. Currently, the US is administering roughly 2.2 million doses of the vaccine a day.

Even if that rate doesn’t improve at all, the US could fully vaccinate more than 140 million Americans by May 1. That’s more than half of the roughly 260 million adults in the US today. So even before Biden’s promised date, the majority of adults in America will be vaccinated.

There’s also very good reason to think the rate will go up. By the end of this month, the pharmaceutical companies have indicated they’ll produce and ship more than 3 million vaccines a day. If states manage to turn those doses into shots in arms as they get them, the US could vaccinate more than 165 million Americans before May — roughly two-thirds of US adults.

And the rate of vaccinations could easily rise above that as supply continues to increase in the coming month and a half.

In other words, Biden’s promise could kick in at a time that only one-third of US adults will still need to get vaccinated, while the country is likely delivering shots at a rate of 3 million doses a day, if not more. At that point, the math simply fits: The remaining 95 million adults in America really could be covered over the span of a month. The only obstacle, if it all goes well, will be making an appointment.

That’s not to say the US is destined to do all of this without any trouble. Maybe the drug companies won’t be able to deliver on the supply they’ve promised. Maybe cities, states, and the feds won’t clear all the logistical hurdles to get shots in arms. Maybe something else will break in a fairly complicated supply chain.

And as supply increases, it’s likely vaccine hesitancy will become a bigger issue as more adults simply refuse a vaccine. Overcoming that — to continue increasing the nationwide rate of vaccinations — will require creative education and awareness campaigns, focused on local pockets of resistance. That will pose its own logistical challenges.

But at least this all seems possible. That wasn’t the case when Biden took office, as the country’s vaccine rollout struggled and fewer than 1 million Americans got a shot a day. Back then, it was unclear if we could vaccinate all US adults by the end of the year. It now looks like America could get the job done in just a few months.



Read original article here

Technology

Another Paradox Game Jumps To The Tabletop, Blows Past Kickstarter Goal

Leave a comment

Image: Stellaris

After the so-so Crusader Kings effort, another Paradox strategy title—Stellaris—is on its way to board gaming after successfully meeting its Kickstarter funding goal.

Not that the goal was ever in question—for a major board game Kickstarter it rarely is—but still, at time of publishing almost 6000 people have backed it/preordered a copy for around USD$940,000 in total funding.

Stellaris the video game is a sprawling 4X affair where you attempt to build a huge space empire, and are responsible for everything from building stuff on planets to diplomacy to research to deciding which guns to put on your spaceships.

The board game…looks pretty similar! What I like about it especially is that it has simultaneous planning, meaning a lot of the “I’m still thinking gimme a minute” deadtime is removed. Also cool: each game only goes for around two hours, but you can expand and continue your civ over multiple sessions, going further down the research trees as you go.

You can see more pics of the minis and art here.

Read original article here

Business

Our goal is bigger than just taking Tesla customers

Leave a comment

The founder and CEO of Fisker told CNBC on Thursday that the electric-vehicle startup is trying to do more than just swipe market share from Tesla.

Henrik Fisker made the comments in an interview on “Mad Money,” one day after his company announced it had inked a key production deal with Foxconn Technology Group. The Taiwan-based firm is best known for its role assembling iPhones for Apple.

“At the end of the day, we’re not out here just to go and take Tesla customers away from Tesla,” Fisker told host Jim Cramer. “That’s great if they come … but the real market opportunity is the 80 million people who buy a new car every year. That’s gigantic opportunity.”

Cramer had asked Fisker how he believes the design of the company’s first expected vehicle, called the Ocean, rivals those from Elon Musk’s Tesla, which is the dominant EV brand in the U.S.

While battery-powered electric vehicles expected to continue growing market share compared with internal combustion engines, the space is growing increasingly crowded. In addition to startups like Fisker, established auto titans like General Motors and Ford are investing heavily.

“We didn’t want to do another ‘me-too’ Tesla. That’s what they’re doing. That’s great, but we really want to do an alternative,” Fisker said, touting the Ocean as a true SUV. “That’s what will be differentiating us from other car companies that are really making hatchbacks or sedans,” he added.

The Ocean, which has a starting price of $37,499, is set to go into production in the fourth quarter of next year. In October, Fisker struck a deal with auto supplier Magna International to manufacture the Ocean.

Fisker, a well-known auto designer whose previous EV startup went on to file for bankruptcy, said the company’s ability to secure high-profile partners in Magna and Foxconn demonstrated its potential.

Fisker and Foxconn have so far signed a memorandum of understanding, with the deal expected to close in the second quarter of 2021. According to the companies, Foxconn plans to make the Fisker’s second vehicle; production is set for the fourth quarter of 2023.

“When it comes with Foxconn, I think that really stamps in steel almost that we have a business model that works. It wasn’t just a one-off thing that we made a deal with Magna,” Fisker said.

Fisker, which last year went public through a reverse merger, saw its stock close down 4.43% Thursday to $21.58 per share. The company released fourth-quarter results after the bell, reporting a loss from operations of $31.3 million.

Read original article here

Sports

Atalanta vs. Real Madrid Champions League score, player ratings: Mendy saves Zidane’s side with late goal

Leave a comment

Real Madrid earned a 1-0 win at Atalanta on Wednesday in their Champions League round of 16 first leg with Ferland Mendy scoring on his only shot. The goal came in the final moments and puts Los Blancos in the driver’s seat to advance to the quarterfinals when they play the second leg in March.

But how did each player perform in this one? Here are our player ratings for the match for every starter, substitute and manager.

All ratings are out of 10, and the higher the number the better. A zero would be a first-minute red card. A 10 would be like a dominant hat trick.

Atalanta

GK – Pierluigi Gollini
He wasn’t too busy, and he was beaten by a fantastic strike. Did everything else well, but could he have done better on the goal? His line of sight seemed blocked.
Rating: 5

DEF – Berat Djimsiti
Positioning could have been better, but the effort was there. He also did well to clear danger and was strong in the air.
Rating: 6

DEF – Cristian Romero
Positioning was good, recovered the ball well, but at times had trouble with Real’s technical ability. Won most of his duels and intercepted the ball five times.
Rating: 7

DEF – Rafael Toloi
A rock at the back, doing a bit of everything. He was strong in his tackles, didn’t get beaten in the air and really helped thwart some runs at goal.
Rating: 7

DEF – Robin Gosens
A menace in defense. He was one of the strongest players on the pitch and could not be beaten when challenged one on one. 
Rating: 8

DEF – Joakim Maehle
Hustled, but his passing was very poor. Always seemed to need an extra touch to get comfortable. Did have his team’s best chance, but it wasn’t even a remotely good one.
Rating: 5

MID – Remo Freuler
Was given a red card after just 17 minutes for a challenge, and it was harsh, to be fair. He didn’t deserve to be sent off, and now he has to miss the second leg. Unfortunate for him,
Rating: N/A

MID – Marten de Roon
With Real dominating the ball, he never really got going and had just 46 touches. He also never got forward, failing to complete one pass in the final third.
Rating: 5

MID – Matteo Pessina
Tasked with being the creative play-maker in the middle, he created zero chances. So, you tell me how his day went.
Rating: 4

FWD – Luis Muriel
Going down to 10 men hampered his opportunities, and he lasted just 56 minutes before being subbed off. It was just one of those days.
Rating: 4

FWD – Duvan Zapata
Picked up a knock in the first half and was subbed off after just 30 minutes.
Rating: N/A

SUB – Mario Pasalic
Played 60 minutes and put in a decent shift.
Rating: 6

SUB – Josip Ilicic
Was on for a half an hour and didn’t get a single look at goal before being taken off. Not good.
Rating: N/A

SUB – Ruslan Malinovskyi
Late sub
Rating: N/A

SUB – Jose Palomino
Another late sub.
Rating: N/A

MANAGER – Gian Piero Gasperini
Red card just torpedoed the team’s attacking plan. A 0-0 draw would have been a fine result all things considered, but now they have their back against the wall. Still, they are more than capable of turning around the slim deficit. It wasn’t all that bad, but the referee did them no favors.
Rating:5

Real Madrid

GK – Thibaut Courtois
He made as many saves as you and I did. A spectator for nearly all of the 90 minutes and had just one corner to worry about.
Rating: 5

DEF – Ferland Mendy
The hero with his second goal of the season, taking it well. He got forward a lot and looked lively early, but nobody saw that goal coming. What a hit.
Rating: 8

DEF – Nacho
Had pretty much nothing to deal with, but he did create a really dangerous chance in attack. He only had to watch his fellow center back in this one as it wasn’t a tough shift.
Rating: 5

DEF – Raphael Varane
Strong as usual, though he wasn’t challenged much. Had 12 recoveries but did struggle a bit in the air with Atalanta’s height, though it didn’t amount to anything.
Rating: 7

DEF – Lucas Vazquez
Not a natural defender, his pace and effort go a long way. Missed badly on a few challenges but did more good than bad.
Rating: 5

MID – Toni Kroos
Created the best chances, was nearly perfect in his passing and really helped to get the attack going after a slow start.
Rating: 7

MID – Casemiro
Very strong in the middle, commanding the game on both ends. Also had some creative moments, but his passing in the final third was a tad off.
Rating: 6

MID – Luka Modric
The Croatian star got the assist and created four chances. He completed nearly 93 percent of his passes and had a good look himself, missing a chance just wide in the second half.
Rating: 7

FWD – Vinicius Jr.
Left his scoring boots in Madrid. Had two shots and should have done better. Was taken off after 57 minutes.
Rating: 5

FWD – Isco
Played in the false nine role and did OK. He created a dangerous chance, had a couple looks himself and put in a good effort in what wasn’t an ideal situation.
Rating: 6

FWD – Marco Asensio
Created next to nothing and wasted a really good free kick in the second half. Played 76 minutes before being taken off.
Rating: 5

SUB – Mariano Diaz
Wonder how he feels about being the only healthy striker yet having Isco start ahead of him. Credit his professionalism and his effort, but he never came close to making an impact after coming on.
Rating: 5

SUB – Hugo Duro
Late substitute.
Rating: N/A

SUB – Sergio Arribas
Another late sub.
Rating: N/A

MANAGER – Zinedine Zidane
It wasn’t pretty, but it was enough, despite an odd lineup. The 0-0 draw would have been solid, but the 1-0 win is a very good result and felt a tad fortunate. But, careful, because this one isn’t even close to being over. Zidane knows that, but this result sets them up nicely.
Rating: 7

require.config({"baseUrl":"https://sportsfly.cbsistatic.com/fly-159/bundles/sportsmediajs/js-build","config":{"version":{"fly/components/accordion":"1.0","fly/components/alert":"1.0","fly/components/base":"1.0","fly/components/carousel":"1.0","fly/components/dropdown":"1.0","fly/components/fixate":"1.0","fly/components/form-validate":"1.0","fly/components/image-gallery":"1.0","fly/components/iframe-messenger":"1.0","fly/components/load-more":"1.0","fly/components/load-more-article":"1.0","fly/components/load-more-scroll":"1.0","fly/components/loading":"1.0","fly/components/modal":"1.0","fly/components/modal-iframe":"1.0","fly/components/network-bar":"1.0","fly/components/poll":"1.0","fly/components/search-player":"1.0","fly/components/social-button":"1.0","fly/components/social-counts":"1.0","fly/components/social-links":"1.0","fly/components/tabs":"1.0","fly/components/video":"1.0","fly/libs/easy-xdm":"2.4.17.1","fly/libs/jquery.cookie":"1.2","fly/libs/jquery.throttle-debounce":"1.1","fly/libs/jquery.widget":"1.9.2","fly/libs/omniture.s-code":"1.0","fly/utils/jquery-mobile-init":"1.0","fly/libs/jquery.mobile":"1.3.2","fly/libs/backbone":"1.0.0","fly/libs/underscore":"1.5.1","fly/libs/jquery.easing":"1.3","fly/managers/ad":"2.0","fly/managers/components":"1.0","fly/managers/cookie":"1.0","fly/managers/debug":"1.0","fly/managers/geo":"1.0","fly/managers/gpt":"4.3","fly/managers/history":"2.0","fly/managers/madison":"1.0","fly/managers/social-authentication":"1.0","fly/utils/data-prefix":"1.0","fly/utils/data-selector":"1.0","fly/utils/function-natives":"1.0","fly/utils/guid":"1.0","fly/utils/log":"1.0","fly/utils/object-helper":"1.0","fly/utils/string-helper":"1.0","fly/utils/string-vars":"1.0","fly/utils/url-helper":"1.0","libs/jshashtable":"2.1","libs/select2":"3.5.1","libs/jsonp":"2.4.0","libs/jquery/mobile":"1.4.5","libs/modernizr.custom":"2.6.2","libs/velocity":"1.2.2","libs/dataTables":"1.10.6","libs/dataTables.fixedColumns":"3.0.4","libs/dataTables.fixedHeader":"2.1.2","libs/dateformat":"1.0.3","libs/waypoints/infinite":"3.1.1","libs/waypoints/inview":"3.1.1","libs/waypoints/jquery.waypoints":"3.1.1","libs/waypoints/sticky":"3.1.1","libs/jquery/dotdotdot":"1.6.1","libs/jquery/flexslider":"2.1","libs/jquery/lazyload":"1.9.3","libs/jquery/maskedinput":"1.3.1","libs/jquery/marquee":"1.3.1","libs/jquery/numberformatter":"1.2.3","libs/jquery/placeholder":"0.2.4","libs/jquery/scrollbar":"0.1.6","libs/jquery/tablesorter":"2.0.5","libs/jquery/touchswipe":"1.6.18","libs/jquery/ui/jquery.ui.core":"1.11.4","libs/jquery/ui/jquery.ui.draggable":"1.11.4","libs/jquery/ui/jquery.ui.mouse":"1.11.4","libs/jquery/ui/jquery.ui.position":"1.11.4","libs/jquery/ui/jquery.ui.slider":"1.11.4","libs/jquery/ui/jquery.ui.sortable":"1.11.4","libs/jquery/ui/jquery.ui.touch-punch":"0.2.3","libs/jquery/ui/jquery.ui.autocomplete":"1.11.4","libs/jquery/ui/jquery.ui.accordion":"1.11.4","libs/jquery/ui/jquery.ui.tabs":"1.11.4","libs/jquery/ui/jquery.ui.menu":"1.11.4","libs/jquery/ui/jquery.ui.dialog":"1.11.4","libs/jquery/ui/jquery.ui.resizable":"1.11.4","libs/jquery/ui/jquery.ui.button":"1.11.4","libs/jquery/ui/jquery.ui.tooltip":"1.11.4","libs/jquery/ui/jquery.ui.effects":"1.11.4","libs/jquery/ui/jquery.ui.datepicker":"1.11.4"}},"shim":{"liveconnection/managers/connection":{"deps":["liveconnection/libs/sockjs-0.3.4"]},"liveconnection/libs/sockjs-0.3.4":{"exports":"SockJS"},"libs/setValueFromArray":{"exports":"set"},"libs/getValueFromArray":{"exports":"get"},"fly/libs/jquery.mobile-1.3.2":["version!fly/utils/jquery-mobile-init"],"libs/backbone.marionette":{"deps":["jquery","version!fly/libs/underscore","version!fly/libs/backbone"],"exports":"Marionette"},"fly/libs/underscore-1.5.1":{"exports":"_"},"fly/libs/backbone-1.0.0":{"deps":["version!fly/libs/underscore","jquery"],"exports":"Backbone"},"libs/jquery/ui/jquery.ui.tabs-1.11.4":["jquery","version!libs/jquery/ui/jquery.ui.core","version!fly/libs/jquery.widget"],"libs/jquery/flexslider-2.1":["jquery"],"libs/dataTables.fixedColumns-3.0.4":["jquery","version!libs/dataTables"],"libs/dataTables.fixedHeader-2.1.2":["jquery","version!libs/dataTables"],"https://sports.cbsimg.net/js/CBSi/app/VideoPlayer/AdobePass-min.js":["https://sports.cbsimg.net/js/CBSi/util/Utils-min.js"]},"map":{"*":{"adobe-pass":"https://sports.cbsimg.net/js/CBSi/app/VideoPlayer/AdobePass-min.js","facebook":"https://connect.facebook.net/en_US/sdk.js","facebook-debug":"https://connect.facebook.net/en_US/all/debug.js","google":"https://apis.google.com/js/plusone.js","google-platform":"https://apis.google.com/js/client:platform.js","google-csa":"https://www.google.com/adsense/search/async-ads.js","google-javascript-api":"https://www.google.com/jsapi","google-client-api":"https://apis.google.com/js/api:client.js","gpt":"https://securepubads.g.doubleclick.net/tag/js/gpt.js","newsroom":"https://c2.taboola.com/nr/cbsinteractive-cbssports/newsroom.js","recaptcha":"https://www.google.com/recaptcha/api.js?onload=loadRecaptcha&render=explicit","recaptcha_ajax":"https://www.google.com/recaptcha/api/js/recaptcha_ajax.js","supreme-golf":"https://sgapps-staging.supremegolf.com/search/assets/js/bundle.js","taboola":"https://cdn.taboola.com/libtrc/cbsinteractive-cbssports/loader.js","twitter":"https://platform.twitter.com/widgets.js","video-utils":"https://sports.cbsimg.net/js/CBSi/util/Utils-min.js"}},"waitSeconds":300});



Read original article here